当前位置:首页 - 行情中心 - 瑞普生物(300119) - 财务分析 - 现金流量表

瑞普生物

(300119)

  

流通市值:64.41亿  总市值:89.37亿
流通股本:3.35亿   总股本:4.65亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,513,837,702.621,657,858,383.59756,952,689.893,170,360,885.84
  收到的税费返还4,901,396.24,220,572.791,980,813.613,607,563.48
  收到其他与经营活动有关的现金499,351,509.18272,922,537.46231,607,476.43921,883,442.19
  经营活动现金流入小计3,018,090,6081,935,001,493.84990,540,979.934,095,851,891.51
  购买商品、接受劳务支付的现金1,412,739,086.4946,628,817.79422,719,182.251,581,089,886.03
  支付给职工以及为职工支付的现金394,426,840.27270,042,876.03139,240,951.96498,737,623.44
  支付的各项税费121,765,847.0987,225,175.7540,056,770.55162,583,806.47
  支付其他与经营活动有关的现金883,278,529.02495,730,932.31314,992,935.031,117,894,368.42
  经营活动现金流出小计2,812,210,302.781,799,627,801.88917,009,839.793,360,305,684.36
  经营活动产生的现金流量净额205,880,305.22135,373,691.9673,531,140.14735,546,207.15
二、投资活动产生的现金流量:
  收回投资收到的现金2,086,276,451.161,034,452,256.34655,498,6323,460,801,367
  取得投资收益收到的现金76,012,964.0641,496,641.225,114,275.8438,268,958.66
  处置固定资产、无形资产和其他长期资产收回的现金净额185,589.883,13133,02363,837.91
  处置子公司及其他营业单位收到的现金净额92,457,781.98---
  收到的其他与投资活动有关的现金34,902.9834,902.9834,902.9837,585,388.89
  投资活动现金流入小计2,254,967,689.981,076,066,931.54660,680,833.823,536,719,552.46
  购建固定资产、无形资产和其他长期资产支付的现金112,457,681.9789,215,614.8463,271,205.52185,337,088.6
  投资支付的现金1,911,673,000868,723,000692,223,0003,562,174,250
  取得子公司及其他营业单位支付的现金170,550,000117,000,000-240,005,230.65
  支付其他与投资活动有关的现金---876,652.78
  投资活动现金流出小计2,194,680,681.971,074,938,614.84755,494,205.523,988,393,222.03
  投资活动产生的现金流量净额60,287,008.011,128,316.7-94,813,371.7-451,673,669.57
三、筹资活动产生的现金流量:
  吸收投资收到的现金6,600,0006,600,0006,600,00027,200,000
  其中:子公司吸收少数股东投资收到的现金6,600,0006,600,0006,600,00020,000,000
  取得借款收到的现金876,364,265.4761,980,000172,930,0801,028,502,502
  收到其他与筹资活动有关的现金6,361,779.396,361,779.3985,171,302.4117,519,750.25
  筹资活动现金流入小计889,326,044.79774,941,779.39264,701,382.411,073,222,252.25
  偿还债务支付的现金776,378,297.4518,698,605.8109,667,000535,579,230
  分配股利、利润或偿付利息支付的现金215,210,742.11183,903,151.7232,303,999.75263,122,582.32
  其中:子公司支付给少数股东的股利、利润54,829,640.0232,405,091.5124,880,092.1847,338,773.87
  支付其他与筹资活动有关的现金153,492,385.83152,348,249.17127,194,519.36407,798,961.59
  筹资活动现金流出小计1,145,081,425.34854,950,006.69269,165,519.111,206,500,773.91
  筹资活动产生的现金流量净额-255,755,380.55-80,008,227.3-4,464,136.7-133,278,521.66
四、汇率变动对现金及现金等价物的影响196,030.85172,814.38163,359.08664,007.64
五、现金及现金等价物净增加额10,607,963.5356,666,595.74-25,583,009.18151,258,023.56
  加:期初现金及现金等价物余额476,225,863.54476,225,863.54476,225,863.54324,967,839.98
  期末现金及现金等价物余额486,833,827.07532,892,459.28450,642,854.36476,225,863.54
补充资料:
  净利润-272,063,586.89-329,833,903.18
  资产减值准备-20,375,065.29-39,305,540.96
  固定资产和投资性房地产折旧-83,233,560.73-151,525,864.71
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-83,233,560.73-151,525,864.71
  无形资产摊销-24,924,978.59-42,507,520.66
  长期待摊费用摊销-240,992.86-750,024.8
  处置固定资产、无形资产和其他长期资产的损失--3,729,955.17-16,698.12
  固定资产报废损失-203,060.76-143,459.09
  公允价值变动损失--43,282,384.88-10,707,752.8
  财务费用-18,553,122.22-32,772,007.09
  投资损失--32,094,818.1--9,142,829.12
  递延所得税-2,959,919.61-409,835.96
  其中:递延所得税资产减少--2,974,736.61--10,716,441.08
    递延所得税负债增加-5,934,656.22-11,126,277.04
  存货的减少--32,408,121.07--22,631,740.31
  经营性应收项目的减少--98,978,935.63--75,822,169.93
  经营性应付项目的增加--82,408,634.92-228,964,276.78
  其他-3,345.25--4,678,265.2
  现金的期末余额-532,892,459.28-476,225,863.54
  减:现金的期初余额-476,225,863.54-324,967,839.98
  现金及现金等价物的净增加额-56,666,595.74-151,258,023.56
公告日期2025-10-252025-08-262025-04-262025-04-03
审计意见(境内)标准无保留意见
TOP↑